HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
1.440
+0.030 (2.13%)
Sep 18, 2025, 9:50 AM EDT - Market open
HeartBeam Market Cap
HeartBeam has a market cap or net worth of $49.41 million as of September 18, 2025. Its market cap has decreased by -20.85% in one year.
Market Cap
49.41M
Enterprise Value
43.33M
1-Year Change
-20.85%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on November 11, 2021, HeartBeam's market cap has increased from $46.53M to $49.41M, an increase of 6.19%. That is a compound annual growth rate of 1.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 48.38M | -22.01% |
| Dec 31, 2024 | 62.04M | 0.26% |
| Dec 29, 2023 | 61.87M | 58.40% |
| Dec 30, 2022 | 39.06M | 62.39% |
| Dec 31, 2021 | 24.05M | -48.30% |
| Nov 11, 2021 | 46.53M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |